A Randomized, Open Label, Balanced, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Bioequivalence Study of Levocetirizine Dihydrochloride 5 mg Tablets With Xyzal 5 mg Tablets in Normal, Healthy, Adult, Human Subjects Under Fasting Condition
Latest Information Update: 07 Dec 2012
At a glance
- Drugs Levocetirizine (Primary)
- Indications Allergic rhinitis
- Focus Pharmacokinetics
- 30 Nov 2012 Primary endpoint amended as reported by ClinicalTrials.gov.
- 22 Mar 2012 New trial record